How researchers improve their research through involving diverse communities
When we involve patients, carers and other members of the public in our research – including them in the design and delivery of our clinical trials and studies – it improves it and ensures it benefits the people and communities who need it most. It is even more important that the voices of people from diverse and under-served communities are heard when we are designing our studies. In this video, researchers explain how involving patients and members of the public from different communities has added value to their research and made it more effective.
Musculoskeletal Diseases: A New Theme for BRC3 – Professor Andrew Carr
Our vision is to build on our strengths in the identification of where to target treatment and to develop drugs tailored to each patient’s individual needs in inflammatory joint disease, degenerative joint disorders and in rare bone diseases. We will also further develop Oxford’s promising tissue engineering implants and devices and regenerative medicine drugs for the benefit of patients.
Orthopaedics in Oxford
The NIHR Oxford Musculoskeletal Biomedical Research Unit aims to translate advances in medical research into benefits for patients within the NHS. Professor Andrew Carr leads the Orthopaedics theme, aiming to improve evidence for the effectiveness of surgery generally and to translate novel biomaterials and biological therapies into the clinic. His group's research will expand current research on muscle, tendon, bone and cartilage to develop new treatments for bone, muscle and tendon conditions, such as osteoporosis and osteoarthritis. The BRU is a collaboration between the Oxford University Hospitals NHS Foundation Trust and the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences of the University of Oxford, funded by the National Institute for Health Research. The strong partnership between the OUH NHS Trust and NDORMS, provides an excellent platform for clinical research which will help to prevent, diagnose and treat ill health. http://www.oxford.msk.bru.nihr.ac.uk/
Treating Early Osteoarthritis and PROMs – lecture by Prof. Andrew Price
Professor Andrew Price, Lead Clinician for Hip and Knee Surgery at the Nuffield Orthopaedic Centre, talks about reducing pain and improving function in joints for the whole of a patient's life, not just immediately following a surgical procedure. He looks at ways of extending the role of PROMs (Patient Recorded Outcome Measures).
Falls, Broken Hips and Research – presentation by Prof. Matthew Costa
Matthew Costa, Professor of Orthopaedic Trauma Surgery, University of Oxford, explores the consequences of hip fracture in older patients, their priorities for recovery from this devastating injury, and the patients’ role in shaping the future of clinical research in this area and beyond.
Researching Rare Diseases of the Skeleton: The RUDY Study
Presented by Dr M Kassim Javid. A disease is defined as rare if it affects less than 1 in 2000 people, but the total number of people in Europe suffering from rare diseases is thought to be over 30 million. Rare Disease Day is designed to bring rare diseases and their impact on patients’ lives to the attention of the general public and decision makers. To mark Rare Disease Day, Dr Kassim Javaid, NDORMS, University of Oxford, discusses how he is transforming the clinical care of patients suffering with rare disorders of the skeleton using patient driven research.